"I believe that the Company's technology has the potential to be a game changer that will dramatically improve the standard of care for patients with an array of CNS disorders for which there are currently no treatments. I am thrilled to be joining StemCells at this important and exciting time for the Company," said Dr. Massey.
STEM closed yesterday (02015.03.24) at $1.03. 52-week range: $0.84 - $2.43.
No comments:
Post a Comment